Genmab A/S (GMAB) Reports FY EPS of $15.37

Genmab A/S (NASDAQ: GMAB) reported FY EPS of $15.37. Revenue for the period came in at $3.72 billion.

For earnings history and earnings-related data on Genmab A/S (GMAB) click here.

You May Also Be Interested In

• Antero Resources (AR) PT Raised to $47 at Benchmark on Natural Gas Bull Case
• Sea Ltd. (SE) PT Raised to $175 at Benchmark on Robust Growth
• Asia Broadband reports record $14.9M in H1 2026 gold and silver revenue